Avadel Pharmaceuticals plc's (AVDL) CEO Gregory Divis on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/17/22
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial ResultsGlobeNewsWire • 03/17/22
Avadel Pharmaceuticals Announces Appointment of Brandi Robinson as Senior Vice President, Corporate AffairsGlobeNewsWire • 03/14/22
Avadel Announces New Positive Data for Once-at-Bedtime FT218 for Narcolepsy and Once-Nightly Dosing Preference Among Patients and Clinicians at World Sleep 2022GlobeNewsWire • 03/11/22
Avadel Pharmaceuticals to Present at the Oppenheimer 32nd Annual Healthcare ConferenceGlobeNewsWire • 03/10/22
Avadel Pharmaceuticals Appoints Dr. Douglas Williamson as Chief Medical OfficerGlobeNewsWire • 02/14/22
Avadel Pharmaceuticals to Present at the 11th Annual SVB Leerink Global Healthcare ConferenceGlobeNewsWire • 02/10/22
Do Options Traders Know Something About Avadel (AVDL) Stock We Don't?Zacks Investment Research • 12/08/21
Avadel Pharmaceuticals plc (AVDL) CEO Gregory Divis on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/08/21
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2021 Financial ResultsGlobeNewsWire • 11/08/21
Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2021 Financial Results on November 8thGlobeNewsWire • 11/01/21
Avadel Presents New Data Supporting Clinical Benefit with Once-at-Bedtime FT218 and Preference for Once-Nightly Dosing in Patients with Narcolepsy at CHEST 2021GlobeNewsWire • 10/19/21
Avadel Pharmaceuticals Announces Ongoing FDA Review of NDA for FT218 for Patients with NarcolepsyGlobeNewsWire • 10/15/21
Avadel Pharmaceuticals Announces Publication of Data from Pivotal Phase 3 REST-ON Trial of FT218 in Adults with Narcolepsy in SLEEPGlobeNewsWire • 08/16/21
Avadel Pharmaceuticals plc (AVDL) CEO Gregory Divis on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/09/21
Avadel Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2021 Financial ResultsGlobeNewsWire • 08/09/21
Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2021 Financial Results on August 9thGlobeNewsWire • 08/02/21
Avadel Pharmaceuticals to Present at the Ladenburg Thalmann Annual Healthcare Conference 2021GlobeNewsWire • 07/07/21